NewLeaf Symbiotics CEO and leadership

Q: Who is the CEO of NewLeaf Symbiotics?

The CEO of NewLeaf Symbiotics is Stephen R Kahn.

Q: Who is the founder of NewLeaf Symbiotics?

Stephen R Kahn, John Pasquesi, David Prend and Thomas Laurita founded NewLeaf Symbiotics.

Zippia score 3.8

NewLeaf Symbiotics CEO and executives

Executive Summary. Based on our data team's research, Stephen R Kahn is the NewLeaf Symbiotics's CEO. NewLeaf Symbiotics has 35 employees, of which 27 are in a leadership position.

Here are further demographic highlights of the leadership team:

The NewLeaf Symbiotics executive team is 11% female and 89% male.
62% of the management team is White.
15% of NewLeaf Symbiotics management is Hispanic or Latino.
10% of the management team is Black or African American.

Work at NewLeaf Symbiotics?

Share your experience

Rate NewLeaf Symbiotics' leaders' effectiveness in guiding the company.

Name & TitleBio

Stephen R Kahn

Chief Executive Officer

Senior executive with substantial experience in venture capital and private equity. Primary responsibility includes building out a global venture capital network and raising capital.

John Pasquesi

Board Member

David Prend

Board Member

Thomas Laurita

Co-Founder

Aaron Kelley

Vice President Manufacturing

Molly Edwards

VP and General Counsel, VP

Natalie Breakfield

VP Research and Discovery

David Flack

Vice President Business Development

Desmond Jimenez

Chief Product Officer

Desmond Jimenez is a Chief Product Officer at NewLeaf Symbiotics Inc. He has worked as VP:Product Development at NewLeaf Symbiotics Inc. Desmond works or has worked at Novo Nordisk; Bayer; and AgraQuest, Inc.. He studied at University of Arizona.

Douglas Bryant

Board Member

Do you work at NewLeaf Symbiotics?

Does the leadership team provide a clear direction for NewLeaf Symbiotics?

NewLeaf Symbiotics jobs

NewLeaf Symbiotics founders

Name & TitleBio

Stephen R Kahn

Chief Executive Officer

Senior executive with substantial experience in venture capital and private equity. Primary responsibility includes building out a global venture capital network and raising capital.

John Pasquesi

Board Member

David Prend

Board Member

Thomas Laurita

Co-Founder

NewLeaf Symbiotics board members

Name & TitleBio

Stephen R Kahn

Chief Executive Officer

Senior executive with substantial experience in venture capital and private equity. Primary responsibility includes building out a global venture capital network and raising capital.

John Pasquesi

Board Member

David Prend

Board Member

Douglas Bryant

Board Member

Michael Frodyma

Board Member

Paul Schickler

Board Member

Alan R. Gould

Board Member

Douglas Cook

Board Member

James Carrington

Board Member

Mark Warner

Board Member

NewLeaf Symbiotics executives FAQs

Who is the CEO of NewLeaf Symbiotics?

Who is the founder of NewLeaf Symbiotics?

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of NewLeaf Symbiotics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NewLeaf Symbiotics. The employee data is based on information from people who have self-reported their past or current employments at NewLeaf Symbiotics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NewLeaf Symbiotics. The data presented on this page does not represent the view of NewLeaf Symbiotics and its employees or that of Zippia.

NewLeaf Symbiotics may also be known as or be related to NewLeaf Symbiotics, NewLeaf Symbiotics Inc, NewLeaf Symbiotics, Inc. and Newleaf Symbiotics, Inc.